From Health Canada:
At Health Canada’s request, Novartis Pharmaceuticals Canada Inc. is suspending marketing and sales of Zelnorm* (tegaserod hydrogen maleate) tablets in Canada to permit further evaluation of important safety information.
For health care professionals
For the public
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment